How Do I Know if Precision Medicine Might Help Me?
Ignyta offers a distinctive combination of next-generation genomic analysis and molecular characterization to ensure that our precision medicines are matched with the patients who may be helped most. Rather than sending your information to a third-party lab, we use our in-house molecular diagnostics (DX) capabilities to identify gene fusions that may respond to our investigational therapies. In this way, even patients with very rare cancers could be helped. We put cancer patients first, keeping in mind how complicated life becomes after receiving a cancer diagnosis and helping you take back control of your story, instead of having it written for you.
Read stories of patients who participated in Ignyta clinical trials, and their impressive results.
Find Out If Ignyta’s Targeted Therapies Might Help You or Someone You Love
If you have been diagnosed with cancer, visit our Clinical Trials page for information on Ignyta’s current clinical trials, or visit STARTRKtrials.com to learn more about molecular diagnostic testing and enrollment in Ignyta’s STARTRK-2 cancer clinical trial.